Allosteric modulation of g protein coupled receptors by cytoplasmic, transmembrane and extracellular ligands

Pharmaceuticals

Volumn 3, Issue 10, 2010, Pages 3324-3342

  Yanamala, Naveena ^a   Klein Seetharaman, Judith ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Allosteric network; Communication; Membrane proteins; Metabotropic glutamate receptors; Rhodopsin

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; METABOTROPIC RECEPTOR; RHODOPSIN;

ALLOSTERISM; BINDING SITE; CRYSTAL STRUCTURE; CYTOPLASM; HUMAN; LIGAND BINDING; MODULATION; MOLECULAR MECHANICS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 78650083742     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3103324     Document Type: Review

References (81)

1. Kolakowski, L.F., Jr. GCRDb: A G-protein-coupled receptor database. Receptors Channels 1994, 2, 1-7.
2. Vassilatis, D.K.; Hohmann, J.G.; Zeng, H.; Li, F.; Ranchalis, J.E.; Mortrud, M.T.; Brown, A.; Rodriguez, S.S.; Weller, J.R.; Wright, A.C.; Bergmann, J.E.; Gaitanaris, G.A. The G proteincoupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. USA 2003, 100, 4903-4908.
3. Finn, R.D.; Tate, J.; Mistry, J.; Coggill, P.C.; Sammut, S.J.; Hotz, H.R.; Ceric, G.; Forslund, K.; Eddy, S.R.; Sonnhammer, E.L.; Bateman, A. The Pfam protein families database. Nucleic Acids Res. 2008, 36, D281-D288.
4. Winzell, M.S.; Ahren, B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol. Ther. 2007, 116, 437-448.
5. Dorsam, R.T.; Gutkind, J.S. G-protein-coupled receptors and cancer. Nat. Rev. Cancer 2007, 7, 79-94.
6. Li, S.; Huang, S.; Peng, S.B. Overexpression of G protein-coupled receptors in cancer cells: Involvement in tumor progression. Int. J. Oncol. 2005, 27, 1329-1339.
7. Yowell, C.W.; Daaka, Y. G protein-coupled receptors provide survival signals in prostate cancer. Clin. Prostate Cancer 2002, 1, 177-181.
8. Conn, P.J.; Christopoulos, A.; Lindsley, C.W. Allosteric modulators of GPCRs: A novel approach for the treatment of CNS disorders. Nat. Rev. Drug. Discov. 2009, 8, 41-54.
9. Yeo, G.S.; Siddle, K. Attractin' more attention - new pieces in the obesity puzzle? Biochem. J. 2003, 376, e7-e8.
10. Lomas-Neira, J.; Ayala, A. Pepducins: An effective means to inhibit GPCR signaling by neutrophils. Trends Immunol. 2005, 26, 619-621.
11. Tang, C.M.; Insel, P.A. GPCR expression in the heart; "new" receptors in myocytes and fibroblasts. Trends Cardiovasc. Med. 2004, 14, 94-99.
12. Fredriksson, R.; Lagerstrom, M.C.; Lundin, L.G.; Schioth, H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 2003, 63, 1256-1272.
13. Bhattacharya, A. Changing Face of GPCR Drug Discovery: Opportunistic Future. In Pharma Focus Asia; Ochre Media Pvt. Lts., Hyderabad, India, 2009.
14. Christopoulos, A.; May, L.T.; Avlani, V.A.; Sexton, P.M. G-protein-coupled receptor allosterism: The promise and the problem(s). Biochem. Soc. Trans. 2004, 32, 873-877.
15. May, L.T.; Leach, K.; Sexton, P.M.; Christopoulos, A. Allosteric modulation of G proteincoupled receptors. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 1-51.
16. Raddatz, R.; Schaffhauser, H.; Marino, M.J. Allosteric approaches to the targeting of G-proteincoupled receptors for novel drug discovery: A critical assessment. Biochem. Pharmacol. 2007, 74, 383-91.
17. Jensen, A.A.; Spalding, T.A. Allosteric modulation of G-protein coupled receptors. Eur. J. Pharm. Sci. 2004, 21, 407-420.
18. Langmead, C.J.; Christopoulos, A. Allosteric agonists of 7TM receptors: Expanding the pharmacological toolbox. Trends Pharmacol. Sci. 2006, 27, 475-481.
19. Christopoulos, A.; Lanzafame, A.; Mitchelson, F. Allosteric interactions at muscarinic cholinoceptors. Clin. Exp. Pharmacol. Physiol. 1998, 25, 185-194.
20. Christopoulos, A.; Kenakin, T. G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 2002, 54, 323-374.
21. Krejci, A.; Tucek, S. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors. Mol. Pharmacol. 2001, 60, 761-767.
22. Huang, X.P.; Prilla, S.; Mohr, K.; Ellis, J. Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: More similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis- [dimethyl-(3-phthalimidopropyl)ammonium]dibromide. Mol. Pharmacol. 2005, 68, 769-778.
23. Prilla, S.; Schrobang, J.; Ellis, J.; Holtje, H.D.; Mohr, K. Allosteric interactions with muscarinic acetylcholine receptors: Complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity. Mol. Pharmacol. 2006, 70, 181-193.
24. Dragic, T.; Trkola, A.; Thompson, D.A.; Cormier, E.G.; Kajumo, F.A.; Maxwell, E.; Lin, S.W.; Ying, W.; Smith, S.O.; Sakmar, T.P.; Moore, J.P. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. USA 2000, 97, 5639-5644.
25. Andrews, G.; Jones, C.; Wreggett, K.A. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5. Mol. Pharmacol. 2008, 73, 855-867.
26. Liaw, C.W.; Grigoriadis, D.E.; Lorang, M.T.; De Souza, E.B.; Maki, R.A. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors. Mol. Endocrinol. 1997, 11, 2048-2053.
27. Hoare, S.R.; Sullivan, S.K.; Ling, N.; Crowe, P.D.; Grigoriadis, D.E. Mechanism of corticotropinreleasing factor type I receptor regulation by nonpeptide antagonists. Mol. Pharmacol. 2003, 63, 751-765.
28. Cascieri, M.A.; Koch, G.E.; Ber, E.; Sadowski, S.J.; Louizides, D.; de Laszlo, S.E.; Hacker, C.; Hagmann, W.K.; MacCoss, M.; Chicchi, G.G.; Vicario, P.P. Characterization of a novel, nonpeptidyl antagonist of the human glucagon receptor. J. Biol. Chem. 1999, 274, 8694-8697.
29. Malherbe, P.; Kratochwil, N.; Knoflach, F.; Zenner, M.T.; Kew, J.N.; Kratzeisen, C.; Maerki, H.P.; Adam, G.; Mutel, V. Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor. J. Biol. Chem. 2003, 278, 8340-8347.
30. Malherbe, P.; Kratochwil, N.; Zenner, M.T.; Piussi, J.; Diener, C.; Kratzeisen, C.; Fischer, C.; Porter, R.H. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine. Mol. Pharmacol. 2003, 64, 823-832.
31. Goudet, C.; Gaven, F.; Kniazeff, J.; Vol, C.; Liu, J.; Cohen-Gonsaud, M.; Acher, F.; Prezeau, L.; Pin, J.P. Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors. Proc. Natl. Acad. Sci. USA 2004, 101, 378-383.
32. O'Brien, J.A.; Lemaire, W.; Chen, T.B.; Chang, R.S.; Jacobson, M.A.; Ha, S.N.; Lindsley, C.W.; Schaffhauser, H.J.; Sur, C.; Pettibone, D.J.; Conn, P.J.; Williams, D.L., Jr. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol. Pharmacol. 2003, 64, 731-740.
33. Hu, J.; Mora, S.; Colussi, G.; Proverbio, M.C.; Jones, K.A.; Bolzoni, L.; De Ferrari, M.E.; Civati, G.; Spiegel, A.M. Autosomal dominant hypocalcemia caused by a novel mutation in the loop 2 region of the human calcium receptor extracellular domain. J. Bone Miner Res. 2002, 17, 1461-1469.
34. Miedlich, S.U.; Gama, L.; Seuwen, K.; Wolf, R.M.; Breitwieser, G.E. Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site. J. Biol. Chem. 2004, 279, 7254-7263.
35. Petrel, C.; Kessler, A.; Maslah, F.; Dauban, P.; Dodd, R.H.; Rognan, D.; Ruat, M. Modeling and mutagenesis of the binding site of Calhex 231, a novel negative allosteric modulator of the extracellular Ca(2+)-sensing receptor. J. Biol. Chem. 2003, 278, 49487-49494.
36. Birdsall, N.J.; Lazareno, S. Allosterism at muscarinic receptors: Ligands and mechanisms. Mini Rev. Med. Chem. 2005, 5, 523-543.
37. Mohr, K.; Trankle, C.; Holzgrabe, U. Structure/activity relationships of M2 muscarinic allosteric modulators. Receptors Channels 2003, 9, 229-240.
38. Kisselev, O.G.; Meyer, C.K.; Heck, M.; Ernst, O.P.; Hofmann, K.P. Signal transfer from rhodopsin to the G-protein: evidence for a two-site sequential fit mechanism. Proc. Natl. Acad. Sci. USA 1999, 96, 4898-4903.
39. Arimoto, R.; Kisselev, O.G.; Makara, G.M.; Marshall, G.R. Rhodopsin-transducin interface: studies with conformationally constrained peptides. Biophys. J. 2001, 81, 3285-3293.
40. Wang, B.; Yang, Y.; Abou-Samra, A.B.; Friedman, P.A. NHERF1 regulates parathyroid hormone receptor desensitization: interference with beta-arrestin binding. Mol. Pharmacol. 2009, 75, 1189-1197.
41. Sneddon, W.B.; Syme, C.A.; Bisello, A.; Magyar, C.E.; Rochdi, M.D.; Parent, J.L.; Weinman, E.J.; Abou-Samra, A.B.; Friedman, P.A. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J. Biol. Chem. 2003, 278, 43787-43796.
42. Balem, F.; Yanamala, N.; Klein-Seetharaman, J. Additive effects of chlorin e6 and metal ion binding on the thermal stability of rhodopsin in vitro. Photochem. Photobiol. 2009, 85, 471-478.
43. Tirupula, K.C.; Balem, F.; Yanamala, N.; Klein-Seetharaman, J. pH-dependent interaction of rhodopsin with cyanidin-3-glucoside. 2. Functional aspects. Photochem. Photobiol. 2009, 85, 463-470.
44. Yanamala, N.; Tirupula, K.C.; Balem, F.; Klein-Seetharaman, J. pH-dependent interaction of rhodopsin with cyanidin-3-glucoside. 1. Structural aspects. Photochem. Photobiol. 2009, 85, 454-462.
45. Taylor, C.M.; Barda, Y.; Kisselev, O.G.; Marshall, G.R. Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening. J. Med. Chem. 2008, 51, 5297-5303.
46. Taylor, C.M.; Rockweiler, N.B.; Liu, C.; Rikimaru, L.; Tunemalm, A.; Kisselev, O.G.; Marshall, G.R. Using Ligand-Based Virtual Screening to Allosterically Stabilize the Activated State of a GPCR. Chem. Biol. Drug Design 2010, 75, 325-332.
47. Hendlich, M.; Rippmann, F.; Barnickel, G. LIGSITE: Automatic and efficient detection of potential small molecule-binding sites in proteins. J. Mol. Graph. Model 1997, 15, 359-363, 389.
48. Washington, I.; Brooks, C.; Turro, N.J.; Nakanishi, K. Porphyrins as photosensitizers to enhance night vision. J. Amer. Chem. Soc. 2004, 126, 9892-9893.
49. Matsumoto, H.; Nakamura, Y.; Tachibanaki, S.; Kawamura, S.; Hirayama, M. Stimulatory effect of cyanidin 3-glycosides on the regeneration of rhodopsin. J. Agr. Food Chem. 2003, 51, 3560-3563.
50. Douglas, R.H.; Partridge, J.C.; Dulai, K.S.; Hunt, D.M.; Mullineaux, C.W.; Hynninen, P.H. Enhanced retinal longwave sensitivity using a chlorophyll-derived photosensitiser in Malacosteus niger, a deep-sea dragon fish with far red bioluminescence. Vision Res. 1999, 39, 2817-2832.
51. Isayama, T.; Alexeev, D.; Makino, C.L.; Washington, I.; Nakanishi, K.; Turro, N.J. An accessory chromophore in red vision. Nature 2006, 443, 649.
52. Washington, I. Chlorophyll derivatives as visual pigments for super vision in the red. Photochem. Photobiol. Sci. 2007, 6, 775-779.
53. Holst, B.; Elling, C.E.; Schwartz, T.W. Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors. J. Biol. Chem. 2002, 277, 47662-47670.
54. Holst, B.; Schwartz, T.W. Molecular mechanism of agonism and inverse agonism in the melanocortin receptors: Zn(2+) as a structural and functional probe. Ann. N Y Acad. Sci. 2003, 994, 1-11.
55. Swaminathan, G.J.; Holloway, D.E.; Colvin, R.A.; Campanella, G.K.; Papageorgiou, A.C.; Luster, A.D.; Acharya, K.R. Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine. Structure 2003, 11, 521-532.
56. Swaminathan, G.J.; Holloway, D.E.; Veluraja, K.; Acharya, K.R. Atomic resolution (0.98 A) structure of eosinophil-derived neurotoxin. Biochemistry 2002, 41, 3341-3352.
57. Shuster, T.A.; Nagy, A.K.; Conly, D.C.; Farber, D.B. Direct zinc binding to purified rhodopsin and disc membranes. Biochem. J. 1992, 282 (Pt 1), 123-128.
58. Stojanovic, A.; Stitham, J.; Hwa, J. Critical role of transmembrane segment zinc binding in the structure and function of rhodopsin. J. Biol. Chem. 2004, 279, 35932-35941.
59. Gleim, S.; Stojanovic, A.; Arehart, E.; Byington, D.; Hwa, J. Conserved rhodopsin intradiscal structural motifs mediate stabilization: effects of zinc. Biochemistry 2009, 48, 1793-1800.
60. Crooks, G.E.; Hon, G.; Chandonia, J.M.; Brenner, S.E. WebLogo: A sequence logo generator. Genome Res. 2004, 14, 1188-1190.
61. Scheerer, P.; Park, J.H.; Hildebrand, P.W.; Kim, Y.J.; Krausz, N.; Choe, H.-W.; Hofmann, K.P.; Ernst, O.P. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008, 455, 497-502.
62. Illingworth, C.J.R.; Scott, P.D.; Parkes, K.E.B.; Snell, C.R.; Campbell, M.P.; Reynolds, C.A. Connectivity and binding-site recognition: Applications relevant to drug design. J. Comput. Chem. 2010, 31, 2677-2688.
63. Thomas, S.M.; Bhola, N.E.; Zhang, Q.; Contrucci, S.C.; Wentzel, A.L.; Freilino, M.L.; Gooding, W.E.; Siegfried, J.M.; Chan, D.C.; Grandis, J.R. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Res. 2006, 66, 11831-11839.
64. Zhang, Q.; Bhola, N.E.; Lui, V.W.; Siwak, D.R.; Thomas, S.M.; Gubish, C.T.; Siegfried, J.M.; Mills, G.B.; Shin, D.; Grandis, J.R. Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer. Mol. Cancer Ther. 2007, 6, 1414-1424.
65. Lui, V.W.; Thomas, S.M.; Zhang, Q.; Wentzel, A.L.; Siegfried, J.M.; Li, J.Y.; Grandis, J.R. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. Oncogene 2003, 22, 6183-6193.
66. Gschwind, A.; Prenzel, N.; Ullrich, A. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res. 2002, 62, 6329-6236.
67. Acher, F.C.; Bertrand, H.O. Amino acid recognition by Venus flytrap domains is encoded in an 8- residue motif. Biopolymers 2005, 80, 357-366.
68. Swanson, C.J.; Bures, M.; Johnson, M.P.; Linden, A.M.; Monn, J.A.; Schoepp, D.D. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat. Rev. Drug Discov. 2005, 4, 131-144.
69. Kew, J.N. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential. Pharmacol. Ther. 2004, 104, 233-244.
70. Dryja, T.P.; McGee, T.L.; Berson, E.L.; Fishman, G.A.; Sandberg, M.A.; Alexander, K.R.; Derlacki, D.J.; Rajagopalan, A.S. Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6. Proc. Natl. Acad. Sci. USA 2005, 102, 4884-4889.
71. Parmentier, M.L.; Prezeau, L.; Bockaert, J.; Pin, J.P. A model for the functioning of family 3 GPCRs. Trends Pharmacol. Sci. 2002, 23, 268-274.
72. Yanamala, N.; Tirupula, K.C.; Klein-Seetharaman, J. Preferential binding of allosteric modulators to active and inactive conformational states of metabotropic glutamate receptors. BMC Bioinformatics 2008, 9 (Suppl. 1), S16.
73. Lockless, S.W.; Ranganathan, R. Evolutionarily conserved pathways of energetic connectivity in protein families. Science 1999, 286, 295-299.
74. Russ, W.P.; Lowery, D.M.; Mishra, P.; Yaffe, M.B.; Ranganathan, R. Natural-like function in artificial WW domains. Nature 2005, 437, 579-583.
75. Socolich, M.; Lockless, S.W.; Russ, W.P.; Lee, H.; Gardner, K.H.; Ranganathan, R. Evolutionary information for specifying a protein fold. Nature 2005, 437, 512-518.
76. Bateman, A.; Birney, E.; Cerruti, L.; Durbin, R.; Etwiller, L.; Eddy, S.R.; Griffiths-Jones, S.; Howe, K.L.; Marshall, M.; Sonnhammer, E.L. The Pfam protein families database. Nucleic Acids Res. 2002, 30, 276-280.
77. Thomas, J.; Ramakrishnan, N.; Bailey-Kellogg, C. Protein design by sampling an undirected graphical model of residue constraints. IEEE/ACM Trans. Comput. Biol. Bioinform. 2009, 6, 506-516.
78. Balakrishnan, S.; Kamisetty, H.; Carbonell, J.C.; Langmead, C.J. Structure Learning for Generative Models of Protein Fold Families. In Research Showcase; Technical Report, Carnegie Mellon University, Pittsburgh, PA, USA, 2009.
79. Balakrishnan, S.; Kamisetty, H.; Carbonell, J.C.; Langmead, C.J. Learning Generative Models for Protein Fold Families. In Research Showcase; Technical Report, Carnegie Mellon University, Pittsburgh, PA, 2010.
80. Moitra, S.; Yanamala, N.; Tastan, O.; Singh, I.; Langmead, C.J.; Klein-Seetharaman, J. Analogies between Structural and Systems Biology and Systems Engineering in Dynamic Environments. In IEEE Conference on Systems of Systems Engineering; IEEE: Loughborough University, Loughborough, UK, 2010.
81. Okada, T.; Fujiyoshi, Y.; Silow, M.; Navarro, J.; Landau, E.M.; Shichida, Y. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc. Natl. Acad. Sci. USA 2002, 99, 5982-5987.